Drug Research
Pfizer And Moderna Omicron Kid Boosters Approved By FDA
Following a decision by the Food and Drug Administration to broaden its authorization of reformulated shots from Moderna and partners Pfizer and BioNTech, kids as young as 5 years old can now receive an updated COVID-19 booster. The vaccine...
News
Can medications affect your fertility? Things to know
If you're thinking about having a baby, your body is a vital vessel that you should take care of. Women who are planning a baby may already be aware that, among other factors, sexually transmitted illnesses, fibroids, excessive weight,...
Clinical Trials
Pistoia Alliance To Explore Clinical Trial Ecology Influence
The Clinical Trials Environmental Impact Community of Interest (CoI) has been launched by The Pistoia Alliance, a global, non-profit alliance that promotes increased collaboration in life sciences R&D. Its goal is to calculate and compare the carbon footprints of...
Drug Research
Stanford Scientists Devise A Breakthrough Cancer Treatment
The molecule tigilanol tiglate, also known as EBC-46, could provide tailored treatment for diseases including cancer, as according research from Stanford University in the US that was recently published in the scientific journal Nature Chemistry.
The chemical is only naturally...
News
Financial Push For CPI RNA Vaccine Innovation Centre In UK
The Centre for Process Innovation (CPI) received a grant of £10.65 million to assist its work in the research, scale-up, and manufacture of RNA therapeutics as well as to finance the training centre already set up at the location,...
News
How ‘First-Time Right’ Formulations Can Help Address the Challenge of Affordable Medicines
For years, global healthcare systems have been facing the triple threat of rising incidences of long-term conditions (LTC), aging populations and dwindling resources. At the same time, we have seen worldwide calls for affordable medicines – from the Jan...
IT & Data Management
Astrazeneca, Mutabor Are Now Recognised As Allies By OPTIMA
The European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have collaborated on the Innovative Medicines Initiative (IMI), which has announced the commencement of the public-private research programme OPTIMA which is defined as Optimal Treatment for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read